文献速递乳房整形与再造美容整形

布比卡因联合地塞米松与脂质体布比卡因用于DIEP皮瓣乳房重建TAP阻滞的疗效比较

Efficacy of Bupivacaine and Dexamethasone versus Liposomal Bupivacaine for Transversus Abdominis Plane Blocks in Free Flap Breast Reconstruction.
PubMed 文献 · Plast Reconstr Surg · 2026-05-15

回顾性单中心研究比较DIEP皮瓣乳房重建中腹横肌平面阻滞使用脂质体布比卡因与布比卡因联合地塞米松的疗效。共纳入178例患者,联合地塞米松组住院时间更短、术后总吗啡当量用量更低、术后第一天疼痛评分更低,后续天数疼痛评分无差异。提示布比卡因联合地塞米松可能是更具成本效益的术后镇痛替代方案。

要点

  • 布比卡因联合地塞米松组住院时间2.88天,短于脂质体布比卡因组的3.49天。
  • 联合地塞米松组术后总吗啡当量用量70.6±60.0,低于脂质体布比卡因组的104.7±72.8。
  • 术后第一天疼痛评分联合地塞米松组3.44±1.50,低于脂质体布比卡因组的4.53±1.57。

核心结论

  • 布比卡因联合地塞米松用于TAP阻滞可能成为DIEP皮瓣乳房重建术后镇痛的成本效益替代方案。

研究设计与样本

  • 回顾性单中心研究,2018-2023年纳入178例接受术中超声引导TAP阻滞的DIEP皮瓣乳房重建患者。
  • 分为两组:组1使用市售脂质体布比卡因(95例),组2使用30 mL 0.25%布比卡因+1 mg地塞米松(83例)。

主要发现

  • 两组在年龄、BMI>30 kg/m²、吸烟状态、侧别、穿支选择及伤口并发症方面无差异。
  • 组2住院时间2.88天 vs 组1 3.49天(p<0.001)。
  • 组2术后总吗啡当量用量70.6±60.0 vs 组1 104.7±72.8(p<0.001)。
  • 组2术后第一天疼痛评分3.44±1.50 vs 组1 4.53±1.57(p<0.001)。
  • 术后第2、3、4天疼痛评分两组无差异。

关键数值与推荐

  • 组2TAP阻滞配方为30 mL 0.25%布比卡因+1 mg地塞米松。
  • 组1使用市售脂质体布比卡因。
  • p<0.05认为有统计学意义。

临床怎么用

  • 在DIEP皮瓣乳房重建的加速康复方案中,可考虑使用布比卡因联合地塞米松替代脂质体布比卡因进行TAP阻滞以降低成本和改善早期镇痛。

局限性

  • 回顾性单中心设计可能引入选择偏倚。
  • 未报告成本数据直接验证成本效益结论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Deep Inferior Epigastric Perforator (DIEP) flap is the most common form of autologous breast reconstruction. Enhanced recovery protocols often include transversus abdominis plane (TAP) blocks using liposomal bupivacaine, but cost limits use. Dexamethasone added to bupivacaine is a low-cost strategy to prolong block duration. We compared the efficacy of liposomal bupivacaine to bupivacaine with dexamethasone for TAP blocks in DIEP patients. A retrospective single-institution study (2018-2023) of DIEP patients receiving intraoperative, ultrasound-guided TAP blocks were identified and divided into two: Group 1 (commercially-available liposomal bupivacaine) and Group 2 (30 mL 0.25% bupivacaine + 1 mg dexamethasone). Outcomes included length of stay (LOS), total post-operative morphine milligram equivalents (MME), and Numeric Pain Rating Scale scores. Demographics were assessed and p<0.05 were considered significant. Among 178 patients (Group 1: 95; Group 2: 83), there was no difference in age, BMI>30 kg/m 2, smoking status, laterality, perforator selection, and wound complications across cohorts. Group 2 had a shorter LOS (2.88 days vs 3.49 days; p<0.001), lower total post-operative MME usage (70.6 ± 60.0 vs 104.7 ± 72.8; p<0.001), and lower pain scores (3.44 ± 1.50 vs 4.53 ± 1.57; p<0.001) on post-operative day one compared to Group 1. No differences were noted in pain scores on subsequent post-operative days (POD 2, 3, 4). TAP blocks using dexamethasone with bupivacaine added may represent a cost-effective and clinically effective alternative approach for post-operative pain management during DIEP flap breast reconstruction compared to commercially marketed liposomal bupivacaine.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Tolo H, Sidhu AS, Massoud L, et al. Efficacy of Bupivacaine and Dexamethasone versus Liposomal Bupivacaine for Transversus Abdominis Plane Blocks in Free Flap Breast Reconstruction. Plast Reconstr Surg. 2026. PMID: 42138392. doi:10.1097/PRS.0000000000013187

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。